Antidepressant-like effect of Cordyceps sinensis in the mouse tail suspension test

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 9, 2007, Pages 1758-1762

  Nishizawa, Koji ^a   Torii, Kosuke ^a   Kawasaki, Aya ^a   Katada, Masanori ^a   Ito, Minoru ^a   Terashita, Kenzo ^b   Aiso, Sadakazu ^b   Matsuoka, Masaaki ^b  

^a Noevir Keio Research Laboratory   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cordyceps sinensis; Depression; Dopamine; Noradrenaline; Tail suspension test

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMFEBUTAMONE; CLORGYLINE; CORDYCEPS SINENSIS EXTRACT; DESIPRAMINE; FENCLONINE; FLUOXETINE; PRAZOSIN; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG ISOLATION; EXPERIMENTAL TEST; HEAD TWITCH; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; SUPERCRITICAL FLUID EXTRACTION; TAIL SUSPENSION TEST;

5-HYDROXYTRYPTOPHAN; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; BUPROPION; CHROMATOGRAPHY, SUPERCRITICAL FLUID; CLORGYLINE; CORDYCEPS; DESIPRAMINE; DOPAMINE ANTAGONISTS; FLUOXETINE; HEAD MOVEMENTS; HINDLIMB SUSPENSION; MALE; MICE; MICE, INBRED C57BL; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; PRAZOSIN; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, DOPAMINE D2; SEROTONIN ANTAGONISTS; SULPIRIDE; WATER;

EID: 34548636468     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1758     Document Type: Article

References (32)

1. Koh J. H., Kim K. M., Kim J. M., Song J. C., Suh H. J., Biol. Pharm. Bull., 26, 691-694 (2003).
2. Bok J. W., Lermer L., Chilton J., Klingeman H. G., Towers G. H., Phytochemistry, 51, 891-898 (1999).
3. Lee H., Kim Y. J., Kim H. W., Lee D. H., Sung M. K., Park T., Biol. Pharm. Bull., 29, 670-674 (2006).
4. Li S. P., Zhao K. J., Ji Z. N., Song Z. H., Dong T. T., Lo C. K., Cheung J. K., Zhu S. Q., Tsim K. W., Life Sci., 73, 2503-2513 (2003).
5. Yamaguchi Y., Kagota S., Nakamura K., Shinozuka K., Kunitomo M., Phytother. Res., 14, 647-649 (2000).
6. Kuo Y. C., Tsai W. J., Wang J. Y., Chang S. C., Lin C. Y., Shiao M. S., Life Sci., 68, 1067-1082 (2001).
7. Koh J. H., Yu K. W., Suh H. J., Choi Y. M., Ahn T. S., Biosci. Biotechnol. Biochem., 66, 407-411 (2002).
8. Wu Y., Sun H., Qin F., Pan Y., Sun C., Phytother. Res., 20, 646-652 (2006).
9. Zhang G., Huang Y., Bian Y., Wong J. H., Ng T. B., Wang H., Appl. Microbiol. Biotechnol., 72, 1152-1156 (2006).
10. Balon T. W., Jasman A. P., Zhu J. S., J. Altern. Complement Med., 8, 315-323 (2002).
11. Chiou W. F., Chang P. C., Chou C. J., Chen C. F., Life Sci., 66, 1369-1376 (2000).
12. Adler R. H., Swiss Med. Wkly., 134, 268-276 (2004).
13. Cathebras P. J., Robbins J. M., Kirmayer L. J., Hayton B. C., J. Gen. Intern. Med., 7, 276-286 (1992).
14. Smith M. S., Martin-Herz S. P., Womack W. M., Marsigan J. L., Pediatrics, 111, e376-e381 (2003).
15. Steru L., Chermat R., Thierry B., Simon P., Psychopharmacology, 85, 367-370 (1985).
16. Steru L., Chermat R., Thierry B., Mico J. A., Lenegre A., Steru M., Simon P., Porsolt R. D., Prog. Neuropsychopharmacol. Biol. Psychiatry, 11, 659-671 (1987).
17. Porsolt R. D., Anton G., Blavet N., Jalfre M., Eur. J. Pharmacol., 47, 379-391 (1978).
18. Schechter L. E., Ring R. H., Beyer C. E., Hughes Z. A., Khawaja X., Malberg J. E., Rosenzweig-Lipson S., NeuroRx., 2, 590-611 (2005).
19. Richelson E., Psychopharmacol. Bull., 36, 133-150 (2002).
20. Tatarczynska E., Antkiewicz-Michaluk L., Klodzinska A., Stachowicz K., Chojnacka-Wojcik E., Eur. J. Pharmacol., 516, 46-50 (2005).
21. Dhingra D., Sharma A., Prog. Neuropsychopharmacol. Biol. Psychiatry, 30, 449-454 (2006).
22. Rodrigues A. L., da Silva G. L., Mateussi A. S., Fernandes E. S., Miguel O. G., Yunes R. A., Calixto J. B., Santos A. R., Life Sci., 70, 1347-1358 (2002).
23. Machado D. G., Kaster M. P., Binfare R. W., Dias M., Santos A. R., Pizzolatti M. G., Brighente I. M., Rodrigues A. L., Prog. Neuropsychopharmacol. Biol. Psychiatry, 31, 421-428 (2007).
24. Corne S. J., Pickering R. W., Warner B. T., Brit. J. Pharmacol., 20, 106-120 (1963).
25. Yoshikawa N., Nakamura K., Yamaguchi Y., Kagota S., Shinozuka K., Kunitomo M., Clin. Exp. Pharmacol. Physiol., 2004 (Suppl. 2), S51-S53 (2004).
26. Wu Y., Sun H., Qin F., Pan Y., Sun C., Phytother. Res., 20, 646-652 (2006).
27. Yalin W., Ishurd O., Cuirong S., Yuanjiang P., Planta Med., 71, 381-384 (2005).
28. Wang B. J., Won S. J., Yu Z. R., Su C. L., Food Chem. Toxicol., 43, 543-552 (2005).
29. Poncelet M., Martin P., Danti S., Simon P., Soubrie P., Pharmacol. Biochem. Behav., 28, 321-326 (1987).
30. Yamada J., Sugimoto Y., Yamada S., Eur. J. Pharmacol., 504, 207-211 (2004).
31. Redrobe J. P., Dumont Y. V., Fournier A., Baker G. B., Quirion R., Peptides, 26, 1394-1400 (2005).
32. Page M. E., Detke M. J., Dalvi A., Kiirby L. G., Lucki I., Psychopharmacology, 147, 162-167 (1999).